Stimcell Energetics (STME) Free Cash Flow Growth (3y) (2016 - 2026)
Stimcell Energetics (STME) Free Cash Flow Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.35 Bn | 175.06 Bn | 6.27 Bn | 6.28% |
| 2 | Stryker | 128.79 Bn | 125.91 Bn | 3.81 Bn | 9.63% |
| 3 | Medtronic | 107.93 Bn | 98.71 Bn | 6.41 Bn | 0.05% |
| 4 | Boston Scientific | 67.82 Bn | 66.37 Bn | 3.61 Bn | 29.36% |
| 5 | Edwards Lifesciences | 48.03 Bn | 44.36 Bn | 1.29 Bn | -27.72% |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 77.20% |
| 7 | GE HealthCare Technologies | 27.90 Bn | 25.62 Bn | 1.98 Bn | -29.89% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.96 Bn | 20.83 Bn | 2.07 Bn | -0.27% |
| 10 | Stimcell Energetics | 5.85 Mn | 5.84 Mn | - | 5.84% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 5.84% |
| Nov 30, 2025 | -3.14% |
| Aug 31, 2025 | -12.65% |
| May 31, 2025 | 14.82% |
| Feb 28, 2025 | 20.73% |
| Nov 30, 2024 | 47.92% |
| Aug 31, 2024 | 46.70% |
| May 31, 2024 | 39.80% |
| Feb 29, 2024 | 27.30% |
| Nov 30, 2023 | 37.42% |
| Aug 31, 2023 | 38.23% |
| May 31, 2023 | 51.91% |
| Feb 28, 2023 | 21.79% |
| Nov 30, 2022 | 37.42% |
| Aug 31, 2022 | 28.40% |
| May 31, 2022 | 2.50% |
| Feb 28, 2022 | 14.83% |
| Nov 30, 2021 | -84.01% |
| Aug 31, 2021 | -48.10% |
| May 31, 2021 | -68.78% |